We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Breast Implant CEO Slams SEC's Stock Fraud 'Scheme' Claim

Law360 (November 20, 2018, 5:44 PM EST) -- A breast implant manufacturing executive denied that his “isolated omission” about defects at a company manufacturing plant constitutes what the government claims was a scheme to defraud investors, according to a...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

California Central

Nature of Suit

850(Securities/Commodities)

Date Filed

September 19, 2018

Law Firms

Companies

Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.